Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100046799Phase 4Recruiting
Phase 4, randomised, double-blind trial of midazolam, propofol, dexmedetomidine, etomidate, esketamine and 2 more in None (7 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoints: State-trait anxiety inventory, Sleep quality scale and 6 more. Started Jun 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100046799.